XENE Operating Income Growth
Xenon Pharmaceuticals Inc · Operating Income Growth
XENE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-38.81%period ending
XENE TTM Operating Income YoY % (689.24% → -38.81%)
Year-over-year change
High-resolution chart · PNG
XENE operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -38.8111% | |
| -40.842% | |
| -33.5742% | |
| -33.3693% | |
| -33.9317% | |
| -30.7757% | |
| -30.4802% | |
| -25.4436% | |
| -27.6091% | |
| -39.3092% | |
| -65.7496% | |
| -84.085% | |
| -111.2279% | |
| -100.2727% | |
| -63.4866% | |
| -64.9572% | |
| -44.0364% | |
| -104.193% | |
| -152.3657% | |
| -123.7724% | |
| -109.3164% | |
| -0.596% | |
| 26.8993% | |
| 24.408% | |
| 34.8781% | |
| 6.8214% | |
| -12.6342% | |
| -5.3729% | |
| -39.8237% | |
| -29.4699% | |
| -16.703% | |
| -25.5019% | |
| -11.9485% | |
| -19.3767% | |
| -31.2608% | |
| -36.5607% | |
| -85.6218% | |
| -205.6294% | |
| -460.2032% | |
| -1,125.3348% | |
| -300.8974% | |
| -200.1579% | |
| -139.8883% | |
| -113.6898% | |
| -29.768% | |
| -12.6908% | |
| 14.3534% | |
| 111.9152% | |
| 689.2357% |